Fig. 3: Tumor responses in the Chemo subgroup. | Nature Communications

Fig. 3: Tumor responses in the Chemo subgroup.

From: Anti-PD1 based precision induction therapy in unresectable stage III non-small cell lung cancer: a phase II umbrella clinical trial

Fig. 3: Tumor responses in the Chemo subgroup.The alternative text for this image may have been generated using AI.

a Swimming plot showing the duration of treatment and clinical events occurrence in the Chemo subgroup (n = 79). b Waterfall plot of pathologic regression in the Chemo subgroup patients with surgical resection after induction treatment (n = 38). RECIST response evaluation criteria in solid tumors, NR, not re-evaluation, PR partial response, SD stable disease, MPR major pathologic response, ICIs, immune checkpoint inhibitors, VATS, video-assisted thoracoscopic surgery, VEGFR, vascular endothelial growth factor receptor; MDT, multidisciplinary team; LUSC, Lung squamous cell carcinoma. Hashtag (#), represents pathological result showed -100% pathological regression ratios but with positive sampled lymph nodes. Source data are provided as a Source Data file.

Back to article page